Fluid-SEA: ICU Fluid Utilization Survey in Southeast Asia

Sponsor
Chulalongkorn University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06034990
Collaborator
(none)
1,000
11

Study Details

Study Description

Brief Summary

The objective of this study is to examine the use of different types of fluids for resuscitation in different phases of fluid management in 3 types of critically ill patients including (1) not bleeding, not septic but need volume resuscitation (representing normal condition), (2) bleeding but not septic (representing normal vascular integrity but with a loss of intravascular colloids), (3) septic (representing the condition with increase vascular permeability and endothelium damage) in the ICU within Southeast Asia.

The data are collected by a 10-min online survey administered to included physicians which will be distributed via multiple online channels through representatives of each countries.

Condition or Disease Intervention/Treatment Phase
  • Other: 10-min online survey

Detailed Description

The objective of this study is to examine the use of different types of fluids for resuscitation in different phases of fluid management in 3 types of critically ill patients including (1) not bleeding, not septic but need volume resuscitation (representing normal condition), (2) bleeding but not septic (representing normal vascular integrity but with a loss of intravascular colloids), (3) septic (representing the condition with increase vascular permeability and endothelium damage) in the ICU within Southeast Asia, and to determine whether co-morbidities with hypoalbuminemia, clinician specialties, hospital practice settings, geographic locations and re-imbursement limitation especially for colloids influence the practice patterns of fluid utilization in different phases in the 3 types of patients. Ultimately, the information provided by this study could also provide basic background information for the design of future clinical trials regarding fluid resuscitation strategies.

The data are collected by a 10-min online survey administered to included physicians which will be distributed via multiple online channels through representatives of each countries.

The survey will start with an inform-consent form prior to starting the survey questions which consist of 13-item questionnaire obtaining information on

  1. Demographics data of clinicians taking the survey on primary specialty, region or country of practice and hospital settings.

  2. Preferences for volume status indicators.

  3. Preferences for fluid resuscitation in 3 types of patients (1. Septic 2. bleeding but not septic 3. not bleeding and not septic) during resuscitation and optimization phase.

  4. Preferences for fluid resuscitation in the 3 types of patients with hypoalbuminemia including (1) cirrhosis (2) nephrotic syndrome (3) other significant hypoalbuminemia during resuscitation/optimization phase and stabilization phase

  5. The reasons for using colloids for volume expansion

  6. The experience of adverse reactions to albumin

  7. The awareness and importance of non-oncotic properties of albumin

  8. The impact of reimbursement for colloids on resuscitation fluid choice

Study Design

Study Type:
Observational
Anticipated Enrollment :
1000 participants
Observational Model:
Other
Time Perspective:
Cross-Sectional
Official Title:
ICU Fluid Utilization Survey in Southeast Asia
Anticipated Study Start Date :
Oct 1, 2023
Anticipated Primary Completion Date :
Sep 1, 2024
Anticipated Study Completion Date :
Sep 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Survey participants

Participants in this cross-sectional survey will be physicians with specialty in Anesthesiology, Surgery, Critical care medicine, Pulmonology, Nephrology, General Medicine currently working in Surgical or Medical ICU in Southeast Asia in year 2023-2024

Other: 10-min online survey
This is a cross-sectional study. The data are collected by a 10-min online survey administered to included physicians which will be distributed via online channels such as such as official website or Facebook pages of Society of intensive care or Society of nephrology of corresponding countries.

Outcome Measures

Primary Outcome Measures

  1. Fluid resuscitation practice pattern [1/9/23-1/9/24]

    Preferences for fluid resuscitation in 3 types of patients (1. Septic 2. bleeding but not septic 3. not bleeding and not septic) during resuscitation and optimization phase.

Secondary Outcome Measures

  1. Preferences for volume status indicators. [1/9/23-1/9/24]

    Preferences for volume status indicators and diagnostic tools

  2. Fluid resuscitation practice pattern in hypoalbuminemic state [1/9/23-1/9/24]

    Preferences for fluid resuscitation in the 3 types of patients with hypoalbuminemia including (1) cirrhosis (2) nephrotic syndrome (3) other significant hypoalbuminemia during resuscitation/optimization phase and stabilization phase

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 60 Years
Sexes Eligible for Study:
All
Inclusion Criteria:
  1. Specialty must be in Anesthesiology, Surgery, Critical Care Medicine, Pulmonology, Nephrology, Internal Medicine, General Practitioner ii. Practice must be in Southeast Asia hospitals iii. Must work in Surgical ICU, Medical ICU , and/or Mixed ICU
Exclusion Criteria:
  • Physicians who worked in cardiac, neurology or pediatric ICUs

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Chulalongkorn University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Nattachai Srisawat ,M.D., Division of Nephrology, Chulalongkorn University
ClinicalTrials.gov Identifier:
NCT06034990
Other Study ID Numbers:
  • IRB.457/66
First Posted:
Sep 13, 2023
Last Update Posted:
Sep 13, 2023
Last Verified:
Sep 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Nattachai Srisawat ,M.D., Division of Nephrology, Chulalongkorn University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 13, 2023